In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)
Session

Event : ESC Congress 2019

Topic : Chronic Heart Failure

  • Session type : Satellite Symposium
  • Date : 31 August 2019
  • Time : 15:30 - 16:30
  • Supported by an unrestricted educational grant from AstraZeneca

5 presentations in this session

Introduction

Event : ESC Congress 2019

  • Session : Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)
  • Speaker : S Anker (Berlin,DE)
  • Supported by an unrestricted educational grant from AstraZeneca

Chronicity and burden of hyperkalaemia in heart failure: an update.

Event : ESC Congress 2019

  • Session : Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)
  • Speaker : M Lainscak (Murska Sobota,SI)
  • Supported by an unrestricted educational grant from AstraZeneca

Hyperkalaemia: a barrier to guideline-recommended RAASi therapy?

Event : ESC Congress 2019

  • Session : Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)
  • Speaker : S Anker (Berlin,DE)
  • Supported by an unrestricted educational grant from AstraZeneca

The management of hyperkalaemia in heart failure: is there room for improvement?

Event : ESC Congress 2019

  • Session : Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)
  • Speaker : M Kosiborod (Kansas,US)
  • Supported by an unrestricted educational grant from AstraZeneca

Towards the state-of-the-art potassium management in heart failure: opportunities and challenges.

Event : ESC Congress 2019

  • Session : Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)
  • Speaker : S Anker (Berlin,DE), M Kosiborod (Kansas,US), M Lainscak (Murska Sobota,SI)
  • Supported by an unrestricted educational grant from AstraZeneca

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are